Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant

Hannah K Eriksson1, Stergios Lazarinis1, Josef D Järhult2

  • 1Department of Surgical Sciences, Section of Orthopaedics, Uppsala University, 751 83 Uppsala, Sweden.

PubMed

Insights

Rifampicin resistance in staphylococci significantly increases the risk of relapse in patients with early periprosthetic joint infection (PJI) treated with debridement, antibiotics, and implant retention (DAIR). This suggests DAIR may be ineffective for PJI caused by resistant strains.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Microbiology

Background:

  • Periprosthetic joint infection (PJI) is a serious complication following joint replacement surgery.
  • Staphylococcal infections are a common cause of PJI.
  • The impact of rifampicin resistance in staphylococci on PJI treatment outcomes remains unclear.

Purpose of the Study:

  • To compare the risk of infection relapse in early PJI patients treated with debridement, antibiotics, and implant retention (DAIR).
  • To evaluate outcomes based on whether the causative staphylococci were resistant or sensitive to rifampicin.

Main Methods:

  • Retrospective analysis of 81 patients with early PJI treated with DAIR.
  • Relapse-free survival estimated using Kaplan-Meier method.
  • Cox regression models used to assess the adjusted risk of infection relapse.

Main Results:

  • Patients with rifampicin-resistant staphylococci had higher relapse rates: 80% after one DAIR, 70% after two.
  • Patients with rifampicin-sensitive bacteria had lower relapse rates: 51% after one DAIR, 33% after two.
  • Rifampicin resistance increased the adjusted risk of relapse by 1.9-fold after one DAIR and 4.1-fold after two DAIR procedures (p < 0.05).

Conclusions:

  • Staphylococcal resistance to rifampicin is linked to poorer outcomes in DAIR treatment for PJI.
  • DAIR may not be a suitable treatment strategy for early PJI caused by rifampicin-resistant staphylococci.
  • Further research into alternative treatment strategies for resistant PJI is warranted.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...